NLS Pharmaceutics Amends Merger Agreement for Sixth Time
Ticker: NCEL · Form: 6-K · Filed: Jul 18, 2025 · CIK: 1783036
| Field | Detail |
|---|---|
| Company | Nls Pharmaceutics LTD. (NCEL) |
| Form Type | 6-K |
| Filed Date | Jul 18, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: merger-agreement, amendment, corporate-action
Related Tickers: NLS
TL;DR
NLS Pharma just inked its SIXTH amendment to the Kadimastem merger deal. Still cooking.
AI Summary
On July 18, 2025, NLS Pharmaceutics Ltd. entered into a sixth amendment to its Merger Agreement with Kadimastem Ltd. and NLS Pharmaceutics (Israel) Ltd. This amendment modifies the terms of the merger agreement originally dated November 4, 2024, with previous amendments occurring on January 30, February 17, May 5, June 5, and July 1, 2025.
Why It Matters
This repeated amendment to the merger agreement suggests ongoing negotiations or complexities in the proposed business combination, which could impact the timeline and final terms for shareholders.
Risk Assessment
Risk Level: medium — Frequent amendments to a merger agreement can indicate underlying issues or complexities that may affect the deal's completion or terms.
Key Players & Entities
- NLS Pharmaceutics Ltd. (company) — Registrant
- Kadimastem Ltd. (company) — Party to Merger Agreement
- NLS Pharmaceutics (Israel) Ltd. (company) — Party to Merger Agreement
- November 4, 2024 (date) — Original Merger Agreement Date
- July 18, 2025 (date) — Date of Sixth Amendment
FAQ
What is the primary purpose of the Sixth Amendment to the Merger Agreement?
The filing indicates that the Sixth Amendment modifies the terms of the Agreement and Plan of Merger, originally dated November 4, 2024.
Who are the parties involved in the Merger Agreement?
The parties involved are NLS Pharmaceutics Ltd., Kadimastem Ltd., and NLS Pharmaceutics (Israel) Ltd.
When was the original Merger Agreement entered into?
The original Merger Agreement was entered into on November 4, 2024.
How many previous amendments have been made to the Merger Agreement before the Sixth Amendment?
There have been five previous amendments made to the Merger Agreement on January 30, 2025, February 17, 2025, May 5, 2025, June 5, 2025, and July 1, 2025.
What is the filing date of this Report of Foreign Private Issuer?
This Report of Foreign Private Issuer (Form 6-K) was filed on July 18, 2025.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 18, 2025 regarding NLS Pharmaceutics Ltd. (NCEL).